|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities | |||||
| Provision for credit losses | |||||
| Depreciation and amortization of premises and equipment | |||||
| Accretion of discounts on investments, net | |||||
| Amortization of intangible assets | |||||
| Accretion on acquired loans | |||||
| Gain on divestiture | |||||
| Equity-based compensation expense | |||||
| Issuance of common stock to 401(k) plan | |||||
| Loss (gain) on sale of premises and equipment, net | |||||
| Provision expense and loss on sale of other real estate owned | |||||
| Loss on sale of securities | |||||
| Dividend payable | |||||
| Increase (decrease) in other operating activities | |||||
| Net cash provided by operating activities | |||||
| Investing activities | |||||
| Proceeds from sale of available for sale securities | |||||
| Proceeds from maturities, prepayments, and calls of securities available for sale | |||||
| Payments to acquire securities available for sale | |||||
| Proceeds from repayments of loans, net | |||||
| Proceeds from bank owned life insurance | |||||
| Redemption of (payments for) FHLB stock, net | |||||
| Net cash provided by acquisitions and divestitures | |||||
| Proceeds from sale of premises and equipment | |||||
| Payments to acquire premises and equipment | |||||
| Proceeds from sale of other real estate owned | |||||
| Net cash provided by investing activities | |||||
| Financing activities | |||||
| Increase (decrease) in noninterest-bearing deposits, net | |||||
| (Decrease) increase in interest-bearing deposits, net | |||||
| Changes in securities sold under agreements to repurchase, net | |||||
| Repayments of FHLB and other borrowings, net | |||||
| Proceeds from stock options exercised | |||||
| Payments for repurchase of common stock | |||||
| Payments of common stock dividends | |||||
| Net cash used in financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Supplemental disclosure -- cash flow information | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Supplemental transactions -- non-cash items | |||||
| Transfer of loans to other real estate | |||||
| Loans originated to finance the sale of other real estate | |||||
| Change in accumulated other comprehensive income/(loss) | |||||
| Acquisitions: | |||||
| Fair value of assets acquired | |||||
| Fair value of liabilities assumed | |||||
| Net assets acquired | |||||
| Common stock issued in acquisition | |||||
Loading...
